Touyun Biotech Group Limited (HKG:1332)
Hong Kong · Delayed Price · Currency is HKD 0.1270
+0.0050 (4.10%)
Feb 13, 2026, 3:58 PM HKT
Touyun Biotech Group Cash Flow Statement
Financials in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | -28.9 | -88.11 | -268.94 | -198.07 | -72.95 | -168.78 |
Depreciation & Amortization | 29.15 | 29.48 | 36.59 | 32.22 | 21.3 | 21.4 |
Other Amortization | - | - | - | 0.92 | 1.41 | 7.05 |
Loss (Gain) From Sale of Assets | 1.03 | 1.03 | 2.05 | 2.82 | 22.91 | -0.64 |
Asset Writedown & Restructuring Costs | - | - | 78.75 | - | - | - |
Loss (Gain) From Sale of Investments | 33.56 | 33.56 | 100.43 | 150.17 | 54.05 | 70.94 |
Loss (Gain) on Equity Investments | - | - | - | - | - | 24.46 |
Stock-Based Compensation | 3.64 | 3.64 | 2.59 | 6.86 | 16.18 | 4.26 |
Provision & Write-off of Bad Debts | 3.9 | 3.9 | 2.48 | 7.9 | 0.46 | 0.27 |
Other Operating Activities | -57.74 | -1.9 | 10.81 | 0.11 | -67.51 | -16.26 |
Change in Accounts Receivable | 1.58 | 1.58 | 5.97 | 15.43 | -142.48 | 11.11 |
Change in Inventory | -9.88 | -9.88 | 3.22 | -2.85 | 0.98 | 2.19 |
Change in Accounts Payable | -3.25 | -3.25 | -12.27 | -25.6 | 34.87 | 12.15 |
Change in Other Net Operating Assets | 28.92 | 28.92 | 18.54 | -23.98 | 68.2 | -37 |
Operating Cash Flow | -46.83 | -49.87 | 2.18 | -26.37 | -53.81 | -15.35 |
Capital Expenditures | -2.37 | -3.66 | -17.13 | -12.93 | -163.51 | -125.51 |
Sale of Property, Plant & Equipment | -0 | 0.43 | 1.19 | 1.15 | 3.28 | 2.73 |
Cash Acquisitions | - | - | - | - | - | 32.79 |
Divestitures | - | - | - | - | 152.08 | - |
Sale (Purchase) of Real Estate | - | - | - | - | -87.28 | - |
Investment in Securities | - | - | -55 | -5.47 | -52.3 | 42.12 |
Other Investing Activities | -0.4 | -1.42 | - | - | - | - |
Investing Cash Flow | -2.77 | -4.66 | -70.95 | -17.25 | -147.74 | -47.87 |
Short-Term Debt Issued | - | 13.08 | 7.66 | 13.9 | - | 140.16 |
Long-Term Debt Issued | - | 91.85 | 106.37 | 315.9 | 348.64 | - |
Total Debt Issued | 114.26 | 104.94 | 114.02 | 329.81 | 348.64 | 140.16 |
Short-Term Debt Repaid | - | - | -1.14 | -3.63 | -16.52 | -1.34 |
Long-Term Debt Repaid | - | -89.19 | -145.1 | -230.54 | -247.33 | -113.2 |
Total Debt Repaid | -90.89 | -89.19 | -146.24 | -234.18 | -263.85 | -114.54 |
Net Debt Issued (Repaid) | 23.37 | 15.74 | -32.21 | 95.63 | 84.79 | 25.63 |
Issuance of Common Stock | - | - | - | - | 31.27 | 119.85 |
Other Financing Activities | 25.33 | 20 | 6 | 7 | 7.12 | 15 |
Financing Cash Flow | 48.7 | 35.74 | -26.21 | 102.63 | 123.17 | 160.47 |
Foreign Exchange Rate Adjustments | 0.36 | 0.61 | 1.37 | 8.89 | -3.86 | 4.73 |
Net Cash Flow | -2.23 | -18.18 | -93.61 | 67.9 | -82.24 | 101.98 |
Free Cash Flow | -49.19 | -53.54 | -14.95 | -39.3 | -217.32 | -140.86 |
Free Cash Flow Margin | -34.25% | -33.47% | -7.53% | -12.44% | -76.66% | -68.12% |
Free Cash Flow Per Share | -0.02 | -0.02 | -0.01 | -0.01 | -0.08 | -0.05 |
Cash Interest Paid | 9.42 | 9.6 | 7.59 | 18.76 | 31.06 | 37.23 |
Cash Income Tax Paid | - | - | 2.53 | 1.51 | 3.3 | -2.56 |
Levered Free Cash Flow | 32.67 | 14.57 | 7.01 | -28.85 | -89.05 | -181.12 |
Unlevered Free Cash Flow | 39.06 | 20.88 | 11.66 | -15.31 | -78.33 | -161.21 |
Change in Working Capital | -29.88 | -29.88 | 34.71 | -29.3 | -23.03 | 35.32 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.